background

Misoprostol added to the WHO Model List of Essential Medicines for the Treatment of PPH

Published
May 1st, 2015
Type
News
Topic
Postpartum Hemorrhage
Authors
Gynuity Health Projects
Downloads

Misoprostol for the treatment of postpartum hemorrhage (PPH) was added to the World Health Organisation’s 19th Model List of Essential Medicines (EML). This one-page document summarizes the decision reached by the 20th Expert Committee on the Selection and Use of Essential Medicines when in April 2015 it met at the WHO Headquarters in Geneva to revise and update the EML for both adults and children.